The Valley Desk

ArticleMolecular therapy. OncologyPublished

CARM1-expressing ovarian cancers are selectively sensitive to HSP70 inhibition

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Lewis Katz School of Medicine, Perelman School of Medicine, Temple University, University of Pennsylvania, The Wistar Institute, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Molecular therapy. Oncology
Published
Subject terms
Ovarian cancer; High-grade Serous Ovarian Cancer; Carm1; Hsp70 Inhibitors
PubMed ID
43061711
PubMed Central ID
PMC13784877
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal